Marqeta ‘s Q2 Beat Earns It Price Target Bump By Analysts Who See Long Term Opportunity
Marqeta, Inc (NASDAQ: MQ)
Why Matterport Is Trading Higher By Around 25%, Here Are 73 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Timber Pharmaceuticals, Inc. (NYSE: TMBR) shares rose 63.8% to $0.1769. Timber Pharmaceuticals recently announced closing of $8.0 million public offering.
Here’s Why Bitcoin- And Ethereum-Related Stock Marqeta Is Getting Hammered
Marqeta Inc (NASDAQ: MQ) shares are trading lower by 17.96% to $9.06 Thursday morning after the company reported second-quarter earnings results.
What Happened?
Keybanc Maintains Overweight on Marqeta, Raises Price Target to $12
Keybanc analyst Josh Beck maintains Marqeta (NASDAQ:MQ) with a Overweight and raises the price target from $11 to $12.
Marqeta: Q2 Earnings Insights
Marqeta (NASDAQ:MQ) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings Scheduled For August 10, 2022
Companies Reporting Before The Bell
• Wix.com (NASDAQ:WIX) is estimated to report earnings for its second quarter.
What Do Analyst Expect From Earnings of Fintech Stocks Block and Marqeta
The general tone from the payments/banking reports "held the line" of a constructive consumer bias in what KeyBanc analyst Josh Beck saw as more of a "rear-view" lens as the next potential catalyst likely linked to improved macro/out-year model clarity.
8 Analysts Have This to Say About Marqeta
Within the last quarter, Marqeta (NASDAQ:MQ) has observed the following analyst ratings: